RIGL
Rigel Pharmaceuticals Inc
NASDAQ: RIGL · HEALTHCARE · BIOTECHNOLOGY
$50.74
+0.38% today
Updated 2026-10-28
Market cap
$932.31M
P/E ratio
2.85
P/S ratio
3.34x
EPS (TTM)
$17.51
Dividend yield
—
52W range
$25 – $52
Volume
0.2M
Rigel Pharmaceuticals Inc (RIGL) Insider transactions
Net insider activity
Net buying (343,229 shares)
Buy transactions
58
Sell transactions
42
All transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-09-02 | SCHORNO, DEAN L | EVP & Chief Financial Officer | Sale | 2,000 | — | — |
| 2026-09-02 | SCHORNO, DEAN L | EVP & Chief Financial Officer | Sale | 1,286 | — | — |
| 2026-09-02 | SCHORNO, DEAN L | EVP & Chief Financial Officer | Sale | 694 | — | — |
| 2026-09-02 | SCHORNO, DEAN L | EVP & Chief Financial Officer | Sale | 620 | — | — |
| 2026-09-02 | SCHORNO, DEAN L | EVP & Chief Financial Officer | Buy | 2,000 | $24.20 | $48400.00 |
| 2026-09-02 | SCHORNO, DEAN L | EVP & Chief Financial Officer | Buy | 1,286 | $24.20 | $31121.20 |
| 2026-09-02 | SCHORNO, DEAN L | EVP & Chief Financial Officer | Buy | 694 | $12.70 | $8813.80 |
| 2026-09-02 | SCHORNO, DEAN L | EVP & Chief Financial Officer | Buy | 620 | $18.70 | $11594.00 |
| 2026-09-01 | SCHORNO, DEAN L | EVP & Chief Financial Officer | Sale | 928 | $47.50 | $44080.00 |
| 2026-09-01 | SANTOS, DAVID A | EVP, Chief Commercial Officer | Sale | 874 | $47.50 | $41515.00 |
| 2026-09-01 | RODRIGUEZ, RAUL R | Director, CEO, President | Sale | 2,424 | $47.50 | $115140.00 |
| 2026-09-01 | FUREY, RAYMOND J. | EVP, GC, CCO & Corp Sec | Sale | 877 | $47.50 | $41657.50 |
| 2026-07-08 | HANNAH, ALISON L. | EVP, Chief Medical Officer | Buy | 24,400 | — | — |
| 2026-06-22 | ALI-JACKSON, KAMIL | Director | Sale | 2,500 | $35.00 | $87500.00 |
| 2026-06-17 | SCHORNO, DEAN L | EVP & Chief Financial Officer | Buy | 7,394 | — | — |
| 2026-06-17 | SANTOS, DAVID A | EVP, Chief Commercial Officer | Buy | 7,394 | — | — |
| 2026-06-17 | ROJKJAER, LISA | EVP, Chief Medical Officer | Buy | 9,375 | — | — |
| 2026-06-17 | ROJKJAER, LISA | EVP, Chief Medical Officer | Buy | 7,394 | — | — |
| 2026-06-17 | RODRIGUEZ, RAUL R | Director, CEO, President | Buy | 31,700 | — | — |
| 2026-06-17 | FUREY, RAYMOND J. | EVP, GC, CCO & Corp Sec | Buy | 7,394 | — | — |
| 2026-06-01 | SCHORNO, DEAN L | EVP & Chief Financial Officer | Sale | 2,181 | — | — |
| 2026-06-01 | SCHORNO, DEAN L | EVP & Chief Financial Officer | Sale | 1,200 | — | — |
| 2026-06-01 | SCHORNO, DEAN L | EVP & Chief Financial Officer | Buy | 2,181 | $12.70 | $27698.70 |
| 2026-06-01 | SCHORNO, DEAN L | EVP & Chief Financial Officer | Buy | 1,200 | $18.70 | $22440.00 |
| 2026-06-01 | SCHORNO, DEAN L | EVP & Chief Financial Officer | Sale | 928 | $29.86 | $27710.08 |
| 2026-06-01 | SANTOS, DAVID A | EVP, Chief Commercial Officer | Sale | 874 | $29.86 | $26097.64 |
| 2026-06-01 | ROJKJAER, LISA | EVP, Chief Medical Officer | Sale | 850 | $29.86 | $25381.00 |
| 2026-06-01 | RODRIGUEZ, RAUL R | Director, CEO, President | Sale | 2,424 | $29.86 | $72380.64 |
| 2026-06-01 | FUREY, RAYMOND J. | EVP, GC, CCO & Corp Sec | Sale | 877 | $29.86 | $26187.22 |
| 2026-05-26 | ALI-JACKSON, KAMIL | Director | Sale | 2,500 | $29.17 | $72925.00 |
| 2026-05-15 | WASMAN, JANE | Director | Buy | 5,750 | — | — |
| 2026-05-15 | MOOS, WALTER H | Director | Buy | 5,750 | — | — |
| 2026-05-15 | MILLER, MICHAEL PATRICK | Director | Buy | 5,750 | — | — |
| 2026-05-15 | LAPOINTE, ANTHONY GREGG | Director | Buy | 5,750 | — | — |
| 2026-05-15 | HANNAH, ALISON L. | Director | Buy | 5,750 | — | — |
| 2026-05-15 | FROHLICH, MARK W | Director | Buy | 5,750 | — | — |
| 2026-05-15 | ALI-JACKSON, KAMIL | Director | Buy | 5,750 | — | — |
| 2026-02-20 | MOOS, WALTER H | Director | Sale | 4,000 | — | — |
| 2026-02-20 | MOOS, WALTER H | Director | Sale | 4,000 | $36.36 | $145440.00 |
| 2026-02-17 | SCHORNO, DEAN L | EVP & Chief Financial Officer | Buy | 20,636 | — | — |
| 2026-02-17 | SANTOS, DAVID A | EVP, Chief Commercial Officer | Buy | 19,430 | — | — |
| 2026-02-17 | ROJKJAER, LISA | EVP, Chief Medical Officer | Buy | 18,894 | — | — |
| 2026-02-17 | RODRIGUEZ, RAUL R | Director, CEO, President | Buy | 53,915 | — | — |
| 2026-02-17 | FUREY, RAYMOND J. | EVP, GC, CCO & Corp Sec | Buy | 19,497 | — | — |
| 2026-02-10 | SCHORNO, DEAN L | EVP & Chief Financial Officer | Sale | 3,546 | $34.62 | $122762.52 |
| 2026-02-10 | SANTOS, DAVID A | EVP, Chief Commercial Officer | Sale | 3,546 | $34.62 | $122762.52 |
| 2026-02-10 | ROJKJAER, LISA | EVP, Chief Medical Officer | Sale | 3,758 | $34.62 | $130101.96 |
| 2026-02-10 | RODRIGUEZ, RAUL R | Director, CEO, President | Sale | 7,607 | $34.62 | $263354.34 |
| 2026-02-10 | FUREY, RAYMOND J. | EVP, GC, CCO & Corp Sec | Sale | 3,546 | $34.62 | $122762.52 |
| 2026-02-02 | SCHORNO, DEAN L | EVP & Chief Financial Officer | Sale | 5,488 | $36.01 | $197622.88 |
| 2026-02-02 | SANTOS, DAVID A | EVP, Chief Commercial Officer | Sale | 5,718 | $36.01 | $205905.18 |
| 2026-02-02 | RODRIGUEZ, RAUL R | Director, CEO, President | Sale | 14,110 | $36.01 | $508101.10 |
| 2026-02-02 | FUREY, RAYMOND J. | EVP, GC, CCO & Corp Sec | Sale | 3,968 | $36.01 | $142887.68 |
| 2026-02-01 | MILLER, MICHAEL PATRICK | Director | Buy | 12,000 | — | — |
| 2026-01-26 | RODRIGUEZ, RAUL R | Director, CEO, President | Sale | 40,000 | — | — |
| 2026-01-26 | RODRIGUEZ, RAUL R | Director, CEO, President | Buy | 40,000 | $27.40 | $1.10M |
| 2026-01-26 | RODRIGUEZ, RAUL R | Director, CEO, President | Sale | 35,424 | $37.00 | $1.31M |
| 2026-01-26 | RODRIGUEZ, RAUL R | Director, CEO, President | Sale | 35,211 | $37.00 | $1.30M |
| 2025-12-22 | SCHORNO, DEAN L | EVP & Chief Financial Officer | Sale | 2,846 | — | — |
| 2025-12-22 | SCHORNO, DEAN L | EVP & Chief Financial Officer | Sale | 1,987 | — | — |
| 2025-12-22 | SCHORNO, DEAN L | EVP & Chief Financial Officer | Sale | 1,667 | — | — |
| 2025-12-22 | SCHORNO, DEAN L | EVP & Chief Financial Officer | Buy | 2,846 | $24.20 | $68873.20 |
| 2025-12-22 | SCHORNO, DEAN L | EVP & Chief Financial Officer | Buy | 1,987 | $20.00 | $39740.00 |
| 2025-12-22 | SCHORNO, DEAN L | EVP & Chief Financial Officer | Buy | 1,667 | $18.70 | $31172.90 |
| 2025-09-15 | SCHORNO, DEAN L | EVP & Chief Financial Officer | Buy | 7,394 | — | — |
| 2025-09-15 | SANTOS, DAVID A | EVP, Chief Commercial Officer | Buy | 7,394 | — | — |
| 2025-09-15 | ROJKJAER, LISA | EVP, Chief Medical Officer | Buy | 7,394 | — | — |
| 2025-09-15 | RODRIGUEZ, RAUL R | Director, CEO, President | Buy | 31,700 | — | — |
| 2025-09-15 | FUREY, RAYMOND J. | EVP, GC, CCO & Corp Sec | Buy | 7,394 | — | — |
| 2025-05-23 | WASMAN, JANE | Director | Buy | 3,000 | — | — |
| 2025-05-23 | WASMAN, JANE | Director | Buy | 2,500 | — | — |
| 2025-05-23 | MOOS, WALTER H | Director | Buy | 3,000 | — | — |
| 2025-05-23 | MOOS, WALTER H | Director | Buy | 2,500 | — | — |
| 2025-05-23 | LAPOINTE, ANTHONY GREGG | Director | Buy | 3,000 | — | — |
| 2025-05-23 | LAPOINTE, ANTHONY GREGG | Director | Buy | 2,500 | — | — |
| 2025-05-23 | HANNAH, ALISON L. | Director | Buy | 3,000 | — | — |
| 2025-05-23 | HANNAH, ALISON L. | Director | Buy | 2,500 | — | — |
| 2025-05-23 | FROHLICH, MARK W | Director | Buy | 1,500 | — | — |
| 2025-05-23 | FROHLICH, MARK W | Director | Buy | 1,250 | — | — |
| 2025-05-23 | ALI-JACKSON, KAMIL | Director | Buy | 3,000 | — | — |
| 2025-05-23 | ALI-JACKSON, KAMIL | Director | Buy | 2,500 | — | — |
| 2025-03-17 | SCHORNO, DEAN L | EVP & Chief Financial Officer | Buy | 7,850 | — | — |
| 2025-03-17 | SCHORNO, DEAN L | EVP & Chief Financial Officer | Buy | 5,625 | — | — |
| 2025-03-17 | SANTOS, DAVID A | EVP, Chief Commercial Officer | Buy | 7,850 | — | — |
| 2025-03-17 | SANTOS, DAVID A | EVP, Chief Commercial Officer | Buy | 6,875 | — | — |
| 2025-03-17 | ROJKJAER, LISA | EVP, Chief Medical Officer | Buy | 9,375 | — | — |
| 2025-03-17 | RODRIGUEZ, RAUL R | Director, CEO, President | Buy | 30,000 | — | — |
| 2025-03-17 | RODRIGUEZ, RAUL R | Director, CEO, President | Buy | 26,250 | — | — |
| 2025-03-17 | FUREY, RAYMOND J. | EVP, GC, CCO & Corp Sec | Buy | 9,375 | — | — |
| 2025-03-17 | FUREY, RAYMOND J. | EVP, GC, CCO & Corp Sec | Buy | 7,850 | — | — |
| 2025-03-06 | FROHLICH, MARK W | Director | Buy | 12,000 | — | — |
| 2025-02-05 | SCHORNO, DEAN L | EVP & Chief Financial Officer | Sale | 1,734 | $21.93 | $38019.68 |
| 2025-02-05 | SANTOS, DAVID A | EVP, Chief Commercial Officer | Sale | 1,796 | $21.93 | $39379.10 |
| 2025-02-05 | RODRIGUEZ, RAUL R | Director, CEO, President | Sale | 4,400 | $21.93 | $96474.40 |
| 2025-02-05 | FUREY, RAYMOND J. | EVP, GC, CCO & Corp Sec | Sale | 1,339 | $21.93 | $29358.91 |
| 2025-02-04 | SCHORNO, DEAN L | EVP & Chief Financial Officer | Sale | 2,036 | $20.92 | $42595.16 |
| 2025-02-04 | SANTOS, DAVID A | EVP, Chief Commercial Officer | Sale | 2,125 | $20.92 | $44457.13 |
| 2025-02-04 | RODRIGUEZ, RAUL R | Director, CEO, President | Sale | 4,952 | $20.92 | $103600.79 |
| 2025-02-04 | FUREY, RAYMOND J. | EVP, GC, CCO & Corp Sec | Sale | 1,448 | $20.92 | $30293.61 |
| 2025-01-29 | SCHORNO, DEAN L | EVP & Chief Financial Officer | Buy | 14,788 | — | — |
Frequently asked questions
Are RIGL insiders buying or selling?
Over the transactions on record, RIGL insiders have been net buyers, with about $5.58M in stock sold across 42 sales, against 10 open-market purchases.
Does insider selling at RIGL mean the stock will fall?
Not by itself. Most executive selling is pre-scheduled through 10b5-1 plans filed months in advance, and insiders sell for diversification, taxes, and liquidity far more often than out of any view on the price. Insider buying is the stronger signal, especially when several insiders buy around the same time, because there is usually only one reason to put personal cash into the stock.
Which RIGL insiders are selling the most?
Recent selling is concentrated in a few names. RODRIGUEZ, RAUL R accounts for the largest share on record, with about $3.77M sold. Selling by one or two individuals matters less than broad selling across the whole leadership team, which is the pattern worth watching.